Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.081166v1, 2007; 10.1373/clinchem.2006.081166
This Article
Right arrow Full Text (PDF)
Right arrow 081166.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.081166v1
53/5/916    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Debray, F.-G.
Right arrow Articles by Lambert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Debray, F.-G.
Right arrow Articles by Lambert, M.

Received on ,
Accepted on ,

Endocrinology and Metabolism

Diagnostic Accuracy of Blood Lactate-to-Pyruvate Molar Ratio in the Differential Diagnosis of Congenital Lactic Acidosis

François-Guillaume Debray 1, Grant A. Mitchell 1, Pierre Allard 2, Brian H. Robinson 3, James A. Hanley 4, Marie Lambert 1*

1 Department of Pediatrics, Ste-Justine Hospital and Université de Montréal, Montreal, Quebec, Canada
2 Department of Clinical Biochemistry, Ste-Justine Hospital and Université de Montréal, Montreal, Quebec, Canada
3 Metabolism Research Programme, Department of Pediatrics and Biochemistry, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada
4 Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

* To whom correspondence should be addressed. E-mail: marie.lambert{at}umontreal.ca.

Background:Although the blood lactate-to-pyruvate (L:P) molar ratio is used to distinguish between pyruvate dehydrogenase deficiency (PDH-D) and other causes of congenital lactic acidosis (CLA), its diagnostic accuracy for differentiating between these 2 types of CLA has not been evaluated formally.

Methods: We conducted a retrospective study of all patients followed for mitochondrial diseases between 1985 and 2005 in a tertiary care pediatric hospital.

Results: At the recommended cut point of ~25, individual median L:P ratio demonstrated low sensitivity and specificity (77% and 91%, respectively) for differentiating between patients with enzymatically proven PDH-D (n = 11) and those with mitochondrial disease but normal pyruvate dehydrogenase (PDH) activity (non-PDH; n = 35). We observed a strong positive association between L:P ratio and blood lactate in non-PDH CLA, whereas this association was weak in PDH-D CLA. Consequently, patient classification based on median L:P ratio showed improved diagnostic accuracy at higher lactate concentrations: for lactate <2.5 mmol/L the area under the ROC curve was not statistically different from 0.5 (P = 0.3), whereas it was statistically different for lactate >2.5 mmol/L. In the 2.5 to 5.0 mmol/L lactate category, the sensitivity and specificity at an optimal cut point of 18.4 were 93% [95% confidence interval (CI), 77%-99%)] and 71% (95% CI, 20%-96%), respectively; for lactate >5.0 mmol/L, with an optimal cut point of 25.8, sensitivity and specificity were 96% (95% CI, 77%-99%) and 100% (95% CI, 59%-100%), respectively.

Conclusion: Usefulness of the L:P ratio for differentiating non-PDH and PDH-D types of CLA increases at higher lactate concentrations.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.